Importantly, these effects seem primed to oppose the downregulation of oxphos genes previously reported in MDD (Atp5j2, Atp5i, Ndufb4, Ndufa5, Mt-atp8) and the well-known depletion of ATP in MDD brain [79, 80]. The gene discussed is ATP5MF; the disease is major depressive disorder.